NCT06148597

Brief Summary

Adequate postoperative analgesia is difficult to achieve in patients undergoing laparoscopic sleeve gastrectomy (LSG). Epidural anesthesia is technically difficult due to subcutaneous fat, which increases the risk of serious complications. Moreover, patients in this condition often have comorbidities that require anticoagulation therapy. Although ultrasound-guided Transversus Abdominis Plane (TAP) block may be useful, it is still controversial. Recently, modified thoracoabdominal nerve block via perichondrial approach (M-TAPA) has been reported as a new and promising technique that provides effective analgesia in the anterior and lateral thoracoabdominal wall. The most common reason for hospitalization after laparoscopic surgery is pain after nausea and vomiting. In addition, superficial and tachypneic breathing resulting from the patient's inability to breathe deeply with pain causes closure of small airways and increase in intrapulmonary shunts, resulting in hypoxia. Postoperative pain management is important not only to prevent pain but also to reduce pulmonary complications that may occur due to changes in lung function and to reduce mortality and morbidity by controlling the stress response. In this study, The investigators investigated the effect of modified thoracoabdominal nerve block via perichondrial approach (M-TAPA) on pulmonary function in patients undergoing laparoscopic bariatric surgery under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 28, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

April 22, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

November 20, 2023

Last Update Submit

April 16, 2025

Conditions

Keywords

obesitypain managementpulmonary functionsrespiratory function test

Outcome Measures

Primary Outcomes (1)

  • FEV1/FVC ratio

    Pulmonary function

    during the procedure

Secondary Outcomes (2)

  • Numerical Rating Scale

    during the procedure

  • opioid consumption

    24 hours after surgery

Study Arms (2)

Group M-TAPA

Procedure: Modified thoracoabdominal nerves block through perichondrial approach (M-TAPA)

Group Control

Interventions

application local anesthetic between internal oblique and transversus abdominis muscle at the level of 10th costal cartilage

Group M-TAPA

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients aged 18-65 who will undergo ASA I-III laparoscopic bariatric surgery

You may qualify if:

  • Between 18-65 years old
  • ASA I-II-III risk group
  • Patients whose approval was obtained through an informed consent form
  • Will undergo laparoscopic bariatric surgery
  • Patients who will cooperate for the PFT test

You may not qualify if:

  • \<18 years and \>65 years
  • ASA ≥ IV
  • % below the expected value in SFT
  • Known diaphragmatic paralysis
  • Having had a myocardial infarction within 1 month
  • Dementia or confusion
  • Lack of cooperation
  • Those with respiratory disease
  • Congestive heart failure
  • Unstable hypertension
  • Had thoracoabdominal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zonguldak Bülent Ecevit University Medicine Faculty

Zonguldak, Kozlu, 67600, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaObesity, MorbidObesity

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 20, 2023

First Posted

November 28, 2023

Study Start

December 1, 2023

Primary Completion

May 30, 2024

Study Completion

July 1, 2024

Last Updated

April 22, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations